Scalable, single-use technologies for purification of lentiviral vectors

10.18609/cgti.2021.067

Cell & Gene Therapy Insights 2021; 7(3), 409

Published: 29 April 2021
FastFacts
Todd Sanderson
Todd Sanderson
Senior Manager – R&D Bioprocessing Group, Pall Corporation
Todd has been with Pall since 2006. He has over 20 years of research experience with expertise in mammalian cell culture, process development and analytical method development. He currently leads the US team of Upstream and Analytics within the R&D Bioprocessing Group. He holds a B.S. in Biochemistry and B.S. in Psychology from Michigan State University. When not at work, Todd enjoys gardening and spending time with his young children

Todd has been with Pall since 2006. He has over 20 years of research experience with expertise in mammalian cell culture, process development and analytical method development. He currently leads the US team of Upstream and Analytics within the R&D Bioprocessing Group. He holds a B.S. in Biochemistry and B.S. in Psychology from Michigan State University. When not at work, Todd enjoys gardening and spending time with his young children

Please note all fields marked with an * are mandatory

View article

Already registered? Login

If you have any problem accessing our content, please email info@insights.bio